June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Collagen hydrogels covalently crosslinked by bioorthogonal click chemistry resist cell-induced contraction while preserving encapsulated corneal stromal cell phenotype
Author Affiliations & Notes
  • Lucia G. Brunel
    Chemical Engineering, Stanford University, Stanford, California, United States
  • Sarah M. Hull
    Chemical Engineering, Stanford University, Stanford, California, United States
  • Patrik K. Johansson
    Materials Science and Engineering, Stanford University, Stanford, California, United States
  • David Myung
    Ophthalmology, Stanford Byers Eye Institute, Stanford University School of Medicine, Stanford, California, United States
    Ophthalmology, VA Palo Alto Health Care System, Palo Alto, California, United States
  • Sarah C. Heilshorn
    Materials Science and Engineering, Stanford University, Stanford, California, United States
  • Footnotes
    Commercial Relationships   Lucia Brunel None; Sarah Hull US20210244659A1, Code P (Patent); Patrik Johansson None; David Myung US20210244659A1, Code P (Patent); Sarah Heilshorn US20210244659A1, Code P (Patent)
  • Footnotes
    Support  NSF CBET 2033302; NSF DMR 2103812; NSF DMR 1808415; NSF DGE 1656518; NIH NEI K08EY028176; NIH Departmental P30-EY026877; RPB Career Development Award; Matilda Ziegler Foundation; VA Rehabilitation Research and Development SPiRE I21 RX003179; Stanford SPARK Translational Research Grant
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 94 – A0192. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lucia G. Brunel, Sarah M. Hull, Patrik K. Johansson, David Myung, Sarah C. Heilshorn; Collagen hydrogels covalently crosslinked by bioorthogonal click chemistry resist cell-induced contraction while preserving encapsulated corneal stromal cell phenotype. Invest. Ophthalmol. Vis. Sci. 2022;63(7):94 – A0192.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Due to the dearth of graft tissue available globally for patients with corneal blindness, improved corneal regeneration will require bioengineered strategies. Collagen hydrogels have demonstrated potential as matrices for corneal mesenchymal stromal cells (cMSCs) but commonly suffer from opacity and cell-induced contraction, affecting the optical properties of the material. We have developed a transparent, bioorthogonally-crosslinked collagen hydrogel with enhanced stability against cMSC-induced contraction while maintaining cell phenotype for improved regenerative potential.

Methods : Covalently-crosslinked collagen hydrogels were formed by strain-promoted azide-alkyne cycloaddition (SPAAC), a bioorthogonal click chemistry. The hydrogel fibrillar microstructure and corresponding transparency were characterized with second harmonic generation microscopy and UV/Vis spectroscopy, respectively. Human cMSCs were encapsulated within SPAAC-crosslinked or non-chemically crosslinked control collagen hydrogels, and the contraction was monitored over time. In addition, cMSC viability, differentiation markers, and secretome within the hydrogels were analyzed using a Live/Dead assay, immunocytochemistry, and a Luminex immunoassay, respectively.

Results : We demonstrated the improved transparency of the SPAAC-crosslinked collagen across the visible light range compared to non-chemically crosslinked collagen (e.g., 98% vs. 52% transmittance at 500 nm), which resulted from the disruption of collagen fibril formation. The SPAAC-crosslinked collagen resisted deformation from encapsulated human cMSCs over 72 h: the non-chemically crosslinked collagen hydrogels contracted to 20% of their initial diameters, while SPAAC-crosslinked collagen did not detectably contract. In addition, the cMSCs in the SPAAC-crosslinked collagen maintained their characteristic phenotype, with high viability (> 90%), expression of the keratocyte differentiation marker aldehyde dehydrogenase 3A1, and secretion of cytokines similar to cMSCs within the non-chemically crosslinked collagen.

Conclusions : Our results indicate that human cMSCs may be successfully encapsulated within SPAAC-crosslinked collagen to create transparent, bioengineered hydrogels that resist cell-induced contraction while simultaneously preserving the corneal cell phenotype.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×